Stepan (NYSE:SCL) is in the early stages of a margin recovery, supported by growth in higher-margin product areas, cost reductions and broader-based volume gains, Chief Financial Officer Ruben Velasquez said during a company presentation. Velasquez said second-quarter EBITDA increased 45% year over
This is the newest page. Registered accounts read further back.